Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3626 3685 3686 3785
This examiner grants 34% of resolved cases
Mark Holcomb is a patent examiner in Tech Center 3700 and Art Unit 3626. He has 492 resolved cases in his record. The allowance rate for these cases is 33.5 percent. This 33.5 percent rate suggests that applicants often face initial rejections. The interview lift is 40.4 percent. This 40.4 percent lift indicates that direct communication with the examiner is a useful strategy for overcoming obstacles in Art Unit 3626.
The median days to allowance is 1610. This 1610-day timeline means that practitioners should plan for a long-term prosecution process. The 492 resolved cases provide a substantial sample size for these metrics. The 40.4 percent interview lift is higher than the 33.5 percent allowance rate. This comparison suggests that the impact of an interview is a major factor in successful outcomes. The 1610-day median is a primary consideration for applicants managing their patent portfolios. These 492 cases define the current statistical profile for the examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18667808 | METHOD OF PROVIDING HEALTH CARE SERVICE, SERVER AND HEALTH CARE DEVICE | Final Rejection | SAMSUNG ELECTRONICS CO., LTD. |
| 18202687 | METHOD AND SYSTEM FOR MITIGATING PHYSICAL RISKS IN AN IOT ENVIRONMENT | Final Rejection | SAMSUNG ELECTRONICS CO., LTD. |
| 19047855 | SYMPTOM UNDERSTANDING ASSIST APPARATUS, SYMPTOM UNDERSTANDING ASSIST METHOD, AND RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 17929939 | INTELLIGENCE ENGINE SYSTEM AND METHOD | Final Rejection | Therabody, Inc. |
| 18459604 | CLINICAL DECISION SUPPORT USING TRANSFORMER-BASED NETWORKS BY IMPUTING BIOMARKERS | Non-Final OA | Siemens Healthcare Diagnostics Inc. |
| 19368835 | SYSTEMS AND METHODS FOR GENERATING CLINICAL HANDOFF SUMMARIES | Non-Final OA | Oracle International Corporation |
| 18467939 | SYSTEMS AND METHODS FOR DETERMINING PERSISTENT DECIDUOUS TEETH RISK | Non-Final OA | Mars, Incorporated |
| 18525595 | KIDNEY HEALTH MONITORING SYSTEM | Non-Final OA | Welch Allyn, Inc. |
| 17812452 | DISCHARGE RISK AND MANAGEMENT | Non-Final OA | Hill-Rom Services, Inc. |
| 19314857 | NURSING CARE INFORMATION SYSTEM | Non-Final OA | BUDDHIST TZU CHI MEDICAL FOUNDATION |
| 18571154 | METHODS TO CHARACTERIZE FUNCTIONAL AND DYSFUNCTIONAL ACUTE INFLAMMATORY RESPONSES TO PATHOLOGIC PROCESSES | Final Rejection | The General Hospital Corporation |
| 19086276 | BREAST CANCER RISK PREDICTION DEVICE AND METHOD | Final Rejection | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 19173916 | MEDICAL SYSTEM FOR DOCUMENTING AND MANAGING A DRUG ADMINISTRATION PROCEDURE, METHOD OF DOCUMENTING AND MANAGING A DRUG ADMINISTRATION PROCEDURE, AND COMPUTER PROGRAM | Final Rejection | B. Braun Melsungen AG |
| 17562295 | System, Method, and Apparatus for Electronic Patient Care | Final Rejection | DEKA Products Limited Partnership |
| 16513867 | System, Method, and Apparatus for Electronic Patient Care | Non-Final OA | DEKA Products Limited Partnership |
| 18121459 | SYSTEMS AND METHODS FOR COLLECTING, ANALYZING, AND SHARING BIO-SIGNAL AND NON-BIO-SIGNAL DATA | Final Rejection | INTERAXON INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy